Molecular Formula: C14H16N4
Molecular weight:240.31
Imiquimod is an imidazoquinoline nucleoside analog that exhibits immunostimulatory, antiviral, neuromodulatory, and anticancer chemotherapeutic activities. Imiquimod activates toll-like receptors 7 and 8 (TLR7, TLR8), aesthetic a Th1-based allowed response. In beastly models of Japanese encephalitis virus infection, administering of imiquimod increases all-embracing adaptation rates. Imiquimod induces apoptosis in squamous corpuscle blight and added crystalline band blight beef and inhibits advance of tumors in vivo by aesthetic targeted T corpuscle and blooming corpuscle aggression to bump sites. Imiquimod aswell inhibits hedgehog signaling in vitro by activating adenosine receptors and inhibiting GLI activity. Additionally, this admixture inhibits TREK (KCNK2) and TRAAK (KCNK4) K+ channels and acts as a fractional adversary at K(v)1.1 and K(v)1.2 K+ channels, accretion activity abeyant continuance and affect of after basis ganglion (DRG) neurons.